TechflierTechflierTechflier
  • Home
  • News
  • Features
  • Spotlight
  • About
    • Mission
    • Services
    • Contact
  • Newsletter
  • Shop
    • All Items
    • By Category
      • Bags
      • T-Shirts
    • Cart
Search
© 2025 Techflier. All Rights Reserved.
Reading: Three European biotech founders on moving cancer science to patients
Share
Font ResizerAa
TechflierTechflier
Font ResizerAa
  • Home
  • News
  • Features
  • Spotlight
  • About
  • Newsletter
  • Shop
Search
  • Home
  • News
  • Features
  • Spotlight
  • About
    • Mission
    • Services
    • Contact
  • Newsletter
  • Shop
    • All Items
    • By Category
    • Cart
Have an existing account? Sign In
Follow US
© 2025 Techflier. All Rights Reserved.
Videos

Three European biotech founders on moving cancer science to patients

Three French deeptech founders compare notes on taking cancer therapies from the lab into patients.

Techflier Staff
Last updated: October 23, 2026 12:19 am
Techflier
Share
SHARE

A Women TechEU roundtable brings together the founders of Alga Biologics, Allogenica and InFocus Therapeutics, each attacking cancer from a different angle: microalgae-based antibody manufacturing, off-the-shelf T-cell therapies and AI-designed small molecules aimed at RNA. The conversation stays on what the work actually takes, from the science to the years between a result and a treatment.

Replika’s founder returns with an assistant built for shared conversations
What LPs actually want from venture funds in 2026
Top 13 Tech Startups from Paris You Need to Know About in 2017
AUM Ventures banks $24M toward deeptech war chest
Robot-use agents arrive as general models learn to move
TAGGED:biotechcancer researchdeeptechEuropeFoundersWomen TechEU
SOURCES:EU-Startups
Share This Article
Facebook Copy Link Print
Previous Article PreScalar gives factory lines a way to update device firmware in place PreScalar gives factory lines a way to update device firmware in place
Next Article Lemkin and O'Driscoll weigh a venture market chasing trillion-dollar outcomes Lemkin and O’Driscoll weigh a venture market chasing trillion-dollar outcomes

Get Some Gear

 

 

 

 

Quick Links

  • News
  • Features
  • Spotlight
  • Newsletter
  • Store

About Techflier

  • About Techflier
  • Services
  • Contact Us
  • Privacy
  • Legal

Indices

TechflierTechflier
Follow US
© 2026 Techflier. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?